Organon & Co revenue growth has been varied year-over-year.

What is OGN's revenue growth rate?

Historical revenue data is available for Organon & Co to analyze growth trends.

How fast is OGN earnings growing?

Earnings growth data is available for Organon & Co analysis.

What is OGN's profit margin?

Profit margin data is available for Organon & Co.

OGN Revenue & Earnings Growth Analysis 2026 - Is Organon & Co Growing?

Growth Summary

Organon & Co (OGN) has experienced challenges in growth. The company operates in the Healthcare sector, specifically in the Drug Manufacturers - General industry.

Over the past 4 years, Organon & Co has achieved a revenue compound annual growth rate (CAGR) of -0.5%, while earnings have grown at -20.5% CAGR.

Latest Revenue

$6.40B

Net Income

$864.00M

5-Year Revenue CAGR

-0.5%

4 years of data

Net Margin

N/A

Latest period

Revenue Growth Over Time

Historical revenue and profitability trends for Organon & Co

The chart above illustrates Organon & Co's revenue trajectory over the past 4 years. The revenue pattern shows the challenges the company has faced in recent periods.

Year-over-Year Growth Rates

Annual percentage change in revenue and earnings

Growth rates provide insight into the momentum of Organon & Co's business.

Profit Margin Trends

How efficiently Organon & Co converts revenue into profit

Understanding Profit Margins

Profit margins reveal how much of each dollar of revenue Organon & Co retains at different stages:

Gross Margin (N/A%): What remains after direct production costs
Operating Margin (N/A%): Profit from core operations before interest and taxes
Net Margin (N/A%): Final profit after all expenses

Future Growth Outlook

Analyst estimates and forward-looking indicators

EPS Estimate 2026

$3.50

Current: $3.36

EPS Estimate 2027

$3.72

6.5% expected growth

Price Target

$9.29

Analyst consensus

What Analysts Are Saying

Wall Street analysts project Organon & Co to continue growing earnings in the coming year. The consensus analyst rating is 3 based on 7 analysts.

Growth Analysis Conclusion

Based on our comprehensive analysis, Organon & Co (OGN) demonstrates declining growth characteristics.

Key Takeaways:

Revenue Growth:, -0.5% CAGR over 4 years
Profitability: demonstrates the company is profitable
Efficiency:

Investment Considerations

This growth analysis provides a comprehensive view of Organon & Co's historical performance and future outlook. Investors should consider these growth metrics alongside valuation, competitive positioning, and broader market conditions when making investment decisions. Past performance does not guarantee future results.